Literature DB >> 11238872

Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5.

T Shioda1, E E Nakayama, Y Tanaka, X Xin, H Liu, A Kawana-Tachikawa, A Kato, Y Sakai, Y Nagai, A Iwamoto.   

Abstract

CCR5 is an essential coreceptor for the cellular entry of R5 strains of human immunodeficiency virus type 1 (HIV-1). CCR5-893(-) is a single-nucleotide deletion mutation which is observed exclusively in Asians (M. A. Ansari-Lari, et al., Nat. Genet. 16:221-222, 1997). This mutant gene produces a CCR5 which lacks the entire C-terminal cytoplasmic tail. To assess the effect of CCR5-893(-) on HIV-1 infection, we generated a recombinant Sendai virus expressing the mutant CCR5 and compared its HIV-1 coreceptor activity with that of wild-type CCR5. Although the mutant CCR5 has intact extracellular domains, its coreceptor activity was much less than that of wild-type CCR5. Flow cytometric analyses and confocal microscopic observation of cells expressing the mutant CCR5 revealed that surface CCR5 levels were greatly reduced in these cells, while cytoplasmic CCR5 levels of the mutant CCR5 were comparable to that of the wild type. Peripheral blood CD4(+) T cells obtained from individuals heterozygous for this allele expressed very low levels of CCR5. These data suggest that the CCR5-893(-) mutation affects intracellular transport of CCR5 and raise the possibility that this mutation also affects HIV-1 transmission and disease progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238872      PMCID: PMC114139          DOI: 10.1128/JVI.75.7.3462-3468.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Cell-dependent mechanisms restrict the HIV type 1 coreceptor activity of US28, a chemokine receptor homolog encoded by human cytomegalovirus.

Authors:  A Ohagen; L Li; A Rosenzweig; D Gabuzda
Journal:  AIDS Res Hum Retroviruses       Date:  2000-01-01       Impact factor: 2.205

2.  Novel variant of the CCR5 gene in a Vietnamese population.

Authors:  M Magierowska; V Lepage; T X Lien; N T Lan; M Guillotel; H Issafras; J M Reynes; H J Fleury; N H Chi; J Y Follezou; P Debré; I Theodorou; F Barré-Sinoussi
Journal:  Microbes Infect       Date:  1999-02       Impact factor: 2.700

3.  Dissociation of ligand-induced internalization of CXCR-4 from its co-receptor activity for HIV-1 Env-mediated membrane fusion.

Authors:  H Hu; T Shioda; T Hori; C Moriya; A Kato; Y Sakai; K Matsushima; T Uchiyama; Y Nagai
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

4.  Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.

Authors:  B Asjö; L Morfeldt-Månson; J Albert; G Biberfeld; A Karlsson; K Lidman; E M Fenyö
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

5.  CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis.

Authors:  F Sellebjerg; H O Madsen; C V Jensen; J Jensen; P Garred
Journal:  J Neuroimmunol       Date:  2000-01-03       Impact factor: 3.478

6.  Use of chemokine receptors by poxviruses.

Authors:  A S Lalani; J Masters; W Zeng; J Barrett; R Pannu; H Everett; C W Arendt; G McFadden
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

7.  CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

Authors:  J Reynes; P Portales; M Segondy; V Baillat; P André; B Réant; O Avinens; G Couderc; M Benkirane; J Clot; J F Eliaou; P Corbeau
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

8.  A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.

Authors:  L G Kostrikis; Y Huang; J P Moore; S M Wolinsky; L Zhang; Y Guo; L Deutsch; J Phair; A U Neumann; D D Ho
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

9.  CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.

Authors:  N Ruffing; N Sullivan; L Sharmeen; J Sodroski; L Wu
Journal:  Cell Immunol       Date:  1998-11-01       Impact factor: 4.868

10.  The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.

Authors:  R P van Rij; S Broersen; J Goudsmit; R A Coutinho; H Schuitemaker
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

View more
  14 in total

Review 1.  Roles of G-protein-coupled receptor dimerization.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

2.  Carboxy-terminus of CXCR7 regulates receptor localization and function.

Authors:  Paramita Ray; Laura Anne Mihalko; Nathaniel L Coggins; Pranav Moudgil; Anna Ehrlich; Kathryn E Luker; Gary D Luker
Journal:  Int J Biochem Cell Biol       Date:  2012-01-25       Impact factor: 5.085

3.  Cell-surface targeting of alpha2-adrenergic receptors -- inhibition by a transport deficient mutant through dimerization.

Authors:  Fuguo Zhou; Catalin M Filipeanu; Matthew T Duvernay; Guangyu Wu
Journal:  Cell Signal       Date:  2005-06-14       Impact factor: 4.315

4.  A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.

Authors:  Emi E Nakayama; Hiroyuki Miyoshi; Yoshiyuki Nagai; Tatsuo Shioda
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.

Authors:  H-F Dong; K Wigmore; M N Carrington; M Dean; J A Turpin; O M Z Howard
Journal:  Genes Immun       Date:  2005-10       Impact factor: 2.676

6.  Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization.

Authors:  Tarja T Leskelä; Jarkko J Lackman; Miia M Vierimaa; Hiroyuki Kobayashi; Michel Bouvier; Ulla E Petäjä-Repo
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

Review 7.  Oligomerization of G-protein-coupled receptors: lessons from the yeast Saccharomyces cerevisiae.

Authors:  Mark C Overton; Sharon L Chinault; Kendall J Blumer
Journal:  Eukaryot Cell       Date:  2005-12

8.  CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations.

Authors:  Anabela C P Picton; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunogenetics       Date:  2012-08-15       Impact factor: 2.846

9.  Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly.

Authors:  Hye Joo Kim; Hyung Joo Lee; Hyojin Kim; Seung Woo Cho; Jin-Soo Kim
Journal:  Genome Res       Date:  2009-05-21       Impact factor: 9.043

10.  CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface.

Authors:  Lamia Achour; Mark G H Scott; Hamasseh Shirvani; Alain Thuret; Georges Bismuth; Catherine Labbé-Jullié; Stefano Marullo
Journal:  Blood       Date:  2008-12-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.